• Mashup Score: 0

    A panel at Japan’s health ministry refused to approve on Wednesday a new Alzheimer’s disease drug jointly developed by Japan’s Eisai Co. and U.S. firm Biogen Inc., saying more data are needed to judge its effectiveness. The drug Aducanumab, already sold in the United States under the name Aduhelm, is designed to reduce plaques called amyloid beta in the brain and inhibit progress of the cognitive…

    Tweet Tweets with this article
    • Japan health ministry refuses to approve @biogen 's new Alzheimer's drug via @kyodo_english https://t.co/mJik54RCsB

  • Mashup Score: 1

    Testing of fertilized eggs during in-vitro fertilization treatment to identify genetic diseases before pregnancy will be expanded to cover conditions that develop after adulthood, the Japan Society of Obstetrics and Gynecology says earlier this year, in a decision already questioned by one disabled group.

    Tweet Tweets with this article
    • Genetic testing of IVF embryos will be expanded to conditions that develop after adulthood, the Japan Society of Obstetrics and Gynecology said earlier this year, in a decision already questioned by one disability rights group. https://t.co/Glg0uaTrnG